A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.


Updates from The Motley Fool

Latest updates on GenVec from Fool.com.


Stock Performance

GNVC vs. S&P 500 | 2 Year Performance
View Interactive GNVC Charts
Sponsored by

Key Data Points

Primary metrics and data points about GenVec.
Current Price: $0.60
Prev Close: $0.60
Open: $0.70
Bid: $0.59
Ask: $0.60
Day's Range: $0.57 - $0.73
52wk Range: $0.35 - $3.69
Volume: 385,960
Avg Vol 65,864
Market Cap: $10.35M
P/E (ttm): -1.46
EPS (ttm): -$0.41
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about GenVec.
CAPS Rating 1 out of 5
 
259 Outperform
22 Underperform
CAPS All Stars
 
34 Outperform
12 Underperform

How do you think GenVec will perform against the market?



You pick for GenVec is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paul H. Fischer, CEO

31% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for GenVec.

A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers